Literature DB >> 29630120

The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis.

Z-X Sheng1, H Yao, Z-Y Cai.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) are now recognized as important regulators of gene expression. The aim of the study was to investigate the role of miR-146b-5p in the TLR4 pathway and provide the basis for the treatment of lupus nephritis.
MATERIALS AND METHODS: The glomerular mesangial cells were cultured in vitro and divided into 3 groups: control group, a group of miR-146b-5p mimic added, and a group of miR-146b-5p inhibitor added. The levels of IL-6 and IL-8 in the cell culture supernatant of the three groups were detected by ELISA. The cell proliferation was detected by MTT. The expressions of MiR-146b-5p and TLR4 pathway-associated factor TRAF6 were detected by RT- PCR. The expression of TRAF6 and IRAK1 protein was detected by Western blot.
RESULTS: The overexpression of miR-146b-5p could reduce the level of IL6 and IL8 in cell culture and inhibit glomerular mesangial cell proliferation in some degree. Also, the overexpression of miR-146b-5p could inhibit the expressions of TLR4 pathway-associated factor TRAF6 and IRAK1mRNA, and the expressions of TRAF6 and IRAK1 protein.
CONCLUSIONS: MiR-146b-5p attenuated the inflammatory response of glomerular mesangial cells by inhibiting the expressions levels of TRAF6 and IRAK1 in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630120     DOI: 10.26355/eurrev_201803_14589

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

Review 1.  Mesangial Cells in Lupus Nephritis.

Authors:  Tamara K Nowling
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

Review 2.  MicroRNAs in kidney injury and disease.

Authors:  Nassim Mahtal; Olivia Lenoir; Claire Tinel; Dany Anglicheau; Pierre-Louis Tharaux
Journal:  Nat Rev Nephrol       Date:  2022-08-16       Impact factor: 42.439

3.  miR-146b-5p and miR-520h Expressions Are Upregulated in Serum of Women with Recurrent Spontaneous Abortion.

Authors:  Maryam Shahidi; Farzad Nazari; Hossein Ghanbarian; Robabeh Taheripanah; Mahsa Hajivalili; Davar Amani
Journal:  Biochem Genet       Date:  2022-01-27       Impact factor: 2.220

4.  Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.

Authors:  Tingting Chen; Cheng Wang; Hanqing Yu; Meng Ding; Cuiping Zhang; Xiaolan Lu; Chen-Yu Zhang; Chunni Zhang
Journal:  EBioMedicine       Date:  2018-11-19       Impact factor: 8.143

5.  Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus.

Authors:  Rachael D Wright; Paraskevi Dimou; Sarah J Northey; Michael W Beresford
Journal:  J Inflamm (Lond)       Date:  2019-11-14       Impact factor: 4.981

6.  Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.

Authors:  Lu Diao; Jin Tao; Yiqi Wang; Ying Hu; Wenfei He
Journal:  Int J Nanomedicine       Date:  2019-11-04

7.  Protective effect of FOXP3-mediated miR-146b-5p/Robo1/NF-κB system on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Jiang Zhu; Gaoli Chen
Journal:  Ann Transl Med       Date:  2020-12

8.  miR-146b-5p promotes colorectal cancer progression by targeting TRAF6.

Authors:  Liangpan Shi; Yibin Su; Zhihua Zheng; Jinyu Qi; Weidong Wang; Cunchuan Wang
Journal:  Exp Ther Med       Date:  2022-01-20       Impact factor: 2.447

9.  Depression of lncRNA MINCR antagonizes LPS-evoked acute injury and inflammatory response via miR-146b-5p and the TRAF6-NFkB signaling.

Authors:  Wei Gao; Ying Zhang
Journal:  Mol Med       Date:  2021-10-03       Impact factor: 6.354

10.  Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes.

Authors:  Sandra Mignot; Nicolas Cagnard; Benoit Albaud; Cécile Bally; Justine Siavellis; Olivier Hermine; Laurent Frenzel
Journal:  J Cell Mol Med       Date:  2020-11-07       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.